Sutro Biopharma Inc (NASDAQ: STRO) on Monday, soared 10.48% from the previous trading day, before settling in for the closing price of $1.05. Within the past 52 weeks, STRO’s price has moved between $0.52 and $4.60.
A company in the Healthcare sector has dropped its sales by -4.05% annually for the last half of the decade. The company achieved an average annual earnings per share of 41.25%. With a float of $78.22 million, this company’s outstanding shares have now reached $84.72 million.
Sutro Biopharma Inc (STRO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sutro Biopharma Inc is 7.73%, while institutional ownership is 66.38%. The most recent insider transaction that took place on Oct 15 ’25, was worth 13,607. In this transaction CHIEF SCIENTIFIC OFFICER of this company bought 17,000 shares at a rate of $0.80, taking the stock ownership to the 71,832 shares. Before that another transaction happened on Oct 15 ’25, when Company’s CFO bought 19,750 for $0.81, making the entire transaction worth $15,998. This insider now owns 19,750 shares in total.
Sutro Biopharma Inc (STRO) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.5 earnings per share (EPS) for the period topping the consensus outlook (set at -0.74) by 0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.73% during the next five years compared to -4.05% drop over the previous five years of trading.
Sutro Biopharma Inc (NASDAQ: STRO) Trading Performance Indicators
Sutro Biopharma Inc (STRO) is currently performing well based on its current performance indicators. A quick ratio of 3.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.52, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.10 in one year’s time.
Technical Analysis of Sutro Biopharma Inc (STRO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.37 million. That was better than the volume of 1.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 59.21%.
During the past 100 days, Sutro Biopharma Inc’s (STRO) raw stochastic average was set at 76.43%, which indicates a significant increase from 72.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1166 in the past 14 days, which was higher than the 0.0773 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9202, while its 200-day Moving Average is $1.0388. However, in the short run, Sutro Biopharma Inc’s stock first resistance to watch stands at $1.2167. Second resistance stands at $1.2733. The third major resistance level sits at $1.3717. If the price goes on to break the first support level at $1.0617, it is likely to go to the next support level at $0.9633. The third support level lies at $0.9067 if the price breaches the second support level.
Sutro Biopharma Inc (NASDAQ: STRO) Key Stats
Market capitalization of the company is 98.33 million based on 84,774K outstanding shares. Right now, sales total 62,040 K and income totals -227,460 K. The company made 63,750 K in profit during its latest quarter, and -11,500 K in sales during its previous quarter.
